The group’s earnings surge was attributed to higher non-operational items including a fair value gain on derivative financial instruments of around $1.46 million compared to a fair value loss of $0.62 million last year. The higher bottomline was also due to a fair value gain on financial assets at fair value through profit or loss of approximately $0.7 million from $0.17 million last year, as well as lower income tax expense of approximately $21,000 due to over provision of income tax in prior financial years stemming from the tax rebate announced by the government.
Catalist-listed HC Surgical Specialists has reported earnings of $8.4 million for the FY2025 ended May 31, 119.4% higher than the $3.9 million posted in FY2024.
Earnings per share (EPS) surged by 117% y-o-y to 5.49 cents, from 2.53 cents previously.
